NCT01489904 - Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2012

Conditions

SialorrheaCerebral Palsy

Interventions

BIOLOGICAL

BOTULINUM NEUROTOXIN TYPE-A

Botulinum toxin type A / First infiltration: 25U in each salivary gland=100 U in Parotid and submandibular glands. 24 weeks after first infiltration is a Second infiltration with 50U Botulinum toxin type -A 25 U in each salivary gland only in parotid glands.

Trial Locations (1)

08035

CEIC Hospital Vall d Hebron, Barcelona